The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cardiovascular disease have been studied extensively. However, it remains unclear to what extent n-3 PUFAs may impact Reverse Cholesterol Transport (RCT). RCT describes a mechanism by which excess cholesterol from peripheral tissues is transported to the liver for hepatobiliary excretion, thereby inhibiting foam cell formation and the development of atherosclerosis. The aim of this review is to summarize the literature and to provide an updated overview of the effects of n-3 PUFAs on key players in RCT, including apoliprotein AI (apoA-I), ATP-binding cassette transporter A1 (ABCA1), ABCG1, apoE, scavenger receptor class B type I (SR-BI), cholesteryl ester transfer ...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease ...
Cholesterol homoeostasis is the result of the fine tuning between intake and disposal of this molecu...
Despite decades of advances in research, death due to cardiometabolic disease remains the largest co...
The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cardiovascular disease ...
Atherosclerosis is characterized by lipid accumulation, inflammatory response, cell death and fibros...
Abstract: To date, the literature on high-density lipoprotein (HDL) levels as an inverse risk factor...
Reverse cholesterol transport (RCT) is a physiological mechanism protecting cells from an excessive ...
This study focused on sterol transporters and transcription factors involved in cholesterol absorpti...
Atherosclerosis is a leading cause of cardiovascular disease worldwide, and hypercholesterolemia is ...
Polyunsaturated fatty acids (PUFA) are a family of lipids including some subgroups identified by the...
Reverse cholesterol transport (RCT) is a physiological mechanism protecting cells from an excessive ...
Plasma levels of high-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) are inversely corre...
The relationship between levels of high-density lipoprotein cholesterol (HDL-C) and cardiovascular (...
Abstract Background Epidemiological and genetic studies suggest that elevated triglyceride (TG)-rich...
Patients with well-controlled low-density lipoprotein cholesterol levels, but persistent high trigly...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease ...
Cholesterol homoeostasis is the result of the fine tuning between intake and disposal of this molecu...
Despite decades of advances in research, death due to cardiometabolic disease remains the largest co...
The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cardiovascular disease ...
Atherosclerosis is characterized by lipid accumulation, inflammatory response, cell death and fibros...
Abstract: To date, the literature on high-density lipoprotein (HDL) levels as an inverse risk factor...
Reverse cholesterol transport (RCT) is a physiological mechanism protecting cells from an excessive ...
This study focused on sterol transporters and transcription factors involved in cholesterol absorpti...
Atherosclerosis is a leading cause of cardiovascular disease worldwide, and hypercholesterolemia is ...
Polyunsaturated fatty acids (PUFA) are a family of lipids including some subgroups identified by the...
Reverse cholesterol transport (RCT) is a physiological mechanism protecting cells from an excessive ...
Plasma levels of high-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) are inversely corre...
The relationship between levels of high-density lipoprotein cholesterol (HDL-C) and cardiovascular (...
Abstract Background Epidemiological and genetic studies suggest that elevated triglyceride (TG)-rich...
Patients with well-controlled low-density lipoprotein cholesterol levels, but persistent high trigly...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease ...
Cholesterol homoeostasis is the result of the fine tuning between intake and disposal of this molecu...
Despite decades of advances in research, death due to cardiometabolic disease remains the largest co...